EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 69 filers reported holding EVELO BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $11 | -92.7% | 58,418 | -37.7% | 0.00% | – |
| Q4 2022 | $151 | -100.0% | 93,841 | -49.2% | 0.00% | – |
| Q3 2022 | $386,000 | -5.4% | 184,663 | -4.4% | 0.00% | – |
| Q2 2022 | $408,000 | +175.7% | 193,134 | +343.7% | 0.00% | – |
| Q1 2022 | $148,000 | -87.2% | 43,529 | -77.1% | 0.00% | – |
| Q4 2021 | $1,152,000 | -50.7% | 189,757 | -42.8% | 0.00% | -100.0% |
| Q3 2021 | $2,336,000 | +236.6% | 331,906 | +556.7% | 0.00% | – |
| Q2 2021 | $694,000 | -48.0% | 50,538 | -59.5% | 0.00% | -100.0% |
| Q1 2021 | $1,335,000 | +177.0% | 124,808 | +212.8% | 0.00% | – |
| Q4 2020 | $482,000 | -39.9% | 39,902 | -73.8% | 0.00% | -100.0% |
| Q3 2020 | $802,000 | +536.5% | 152,140 | +491.6% | 0.00% | – |
| Q2 2020 | $126,000 | +193.0% | 25,715 | +125.1% | 0.00% | – |
| Q1 2020 | $43,000 | – | 11,423 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 18,233,403 | $215,154,000 | 41.21% |
| HARBOURVEST PARTNERS LLC | 1,763,505 | $20,809,000 | 26.29% |
| Alphabet Inc. | 1,060,495 | $12,514,000 | 1.05% |
| SECTORAL ASSET MANAGEMENT INC | 437,500 | $5,163,000 | 0.58% |
| DC Investments Management, LLC | 36,924 | $436,000 | 0.28% |
| ARK Investment Management | 126,831 | $1,497,000 | 0.06% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 22,998 | $271,000 | 0.03% |
| Laurion Capital Management LP | 150,000 | $1,770,000 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 9,380 | $111,000 | 0.01% |
| CREDIT SUISSE AG/ | 440,169 | $5,194,000 | 0.01% |